side effects semaglutide vs tirzepatide which has less or While these medication both work great for weight loss, there are differences that set them Weight Loss Blog – Maryland

The evidence for midlife women is growing A 2025 review in Current Opinion in Obstetrics and Gynecology concluded that GLP1 receptor agonists are among the most effective medications for weight loss and may be valuable for peri- and postmenopausal women, while noting that more population-specific data are needed

In the past, cost and insurance uncertainties have been significant barriers to treatment

When it comes to diabetes and brain fog, the best way to keep your blood sugar in control and your brain in its sharp shape is that you should limit the added sugars you consume

Retatrutide: A Triple Agonist with Unprecedented Efficacy Retatrutide (LY3437943) is a novel triple incretin agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

Do you have a question about Ozempic or weight loss